21.07.2014 • News

Texas Judge Upholds $3 Million Fracking Verdict

A judge in the US state of Texas has upheld a $3 million jury verdict by ruling in favor of a family who claimed that oil and gas drilling near their land made them sick. The landmark case is being hailed as a victory by anti-fracking activists.

The Texas ruling is the latest step in a three-year case that began when Bob and Lisa Parr filed suit against a handful of oil companies claiming that fumes from drilling around their 40-acre (16-hectare) ranch exposed them and their livestock to hazardous gases and industrial chemicals.

Some of the initial claims related to hydraulic fracturing, or fracking, operations were settled out of court or dismissed, but the complaint against Aruba Petroleum was sent to a jury trial in Dallas County Court, becoming one of first to reach this stage of litigation.

In April, the jury awarded the Parrs $275,000 for the drop in their property value, $2.4 million for past physical suffering and mental anguish and $250,000 for future harm.

A move by Aruba to overrule the judgment was denied, but the oil company, focused on the Barnett shale formation in Texas, will request a new trial and if that fails will appeal the ruling, its lawyer said.

The Parr family was featured in the anti-fracking documentary Gasland Part II by filmmaker Josh Fox. Its claims were not about fracking per se but instead about air emissions on the surface from diesel-powered trucks and gas wells.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read